Cataracts in setting of multisystem inflammation after COVID-19 vaccination

Diana H. Kim; David Hsu; Yafeng Li; Michael E. Sulewski

doi:10.1016/j.ajoc.2022.101654

Cataracts in setting of multisystem inflammation after COVID-19 vaccination

Diana H. Kim, David Hsu, Yafeng Li, Michael E. Sulewski

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. Observations: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/20 to 20/300–20/400 in each eye, likely from systemic inflammation after vaccination. Conclusion and importance: This is the first reported case of cataract formation following a COVID-19 vaccine. While ocular adverse effects associated with COVID-19 vaccination are rare, it is important to raise awareness of these entities amongst medical providers as the COVID-19 pandemic continues and vaccinations become widespread.

Original language	English (US)
Article number	101654
Journal	American Journal of Ophthalmology Case Reports
Volume	27
DOIs	https://doi.org/10.1016/j.ajoc.2022.101654
State	Published - Sep 2022
Externally published	Yes

Keywords

COVID-19
Cataracts
Coronavirus
Multisystem inflammatory syndrome-vaccine
Post-vaccination inflammation

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ajoc.2022.101654

Cite this

@article{5fb497ebffde471a998f9fa0259aa566,

title = "Cataracts in setting of multisystem inflammation after COVID-19 vaccination",

abstract = "Purpose: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. Observations: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/20 to 20/300–20/400 in each eye, likely from systemic inflammation after vaccination. Conclusion and importance: This is the first reported case of cataract formation following a COVID-19 vaccine. While ocular adverse effects associated with COVID-19 vaccination are rare, it is important to raise awareness of these entities amongst medical providers as the COVID-19 pandemic continues and vaccinations become widespread.",

keywords = "COVID-19, Cataracts, Coronavirus, Multisystem inflammatory syndrome-vaccine, Post-vaccination inflammation",

author = "Kim, {Diana H.} and David Hsu and Yafeng Li and Sulewski, {Michael E.}",

note = "Funding Information: No funding or grant support. Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = sep,

doi = "10.1016/j.ajoc.2022.101654",

language = "English (US)",

volume = "27",

journal = "American Journal of Ophthalmology Case Reports",

issn = "2451-9936",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Cataracts in setting of multisystem inflammation after COVID-19 vaccination

AU - Kim, Diana H.

AU - Hsu, David

AU - Li, Yafeng

AU - Sulewski, Michael E.

PY - 2022/9

Y1 - 2022/9

N2 - Purpose: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. Observations: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/20 to 20/300–20/400 in each eye, likely from systemic inflammation after vaccination. Conclusion and importance: This is the first reported case of cataract formation following a COVID-19 vaccine. While ocular adverse effects associated with COVID-19 vaccination are rare, it is important to raise awareness of these entities amongst medical providers as the COVID-19 pandemic continues and vaccinations become widespread.

AB - Purpose: To describe a unique case of bilateral cataract formation in the setting of multisystem inflammation after the 1st dose of the BNT162b2 mRNA COVID-19 vaccination. Observations: A previously healthy 20-year-old male developed intumescent bilateral cataracts leading to visual decline from 20/20 to 20/300–20/400 in each eye, likely from systemic inflammation after vaccination. Conclusion and importance: This is the first reported case of cataract formation following a COVID-19 vaccine. While ocular adverse effects associated with COVID-19 vaccination are rare, it is important to raise awareness of these entities amongst medical providers as the COVID-19 pandemic continues and vaccinations become widespread.

KW - COVID-19

KW - Cataracts

KW - Coronavirus

KW - Multisystem inflammatory syndrome-vaccine

KW - Post-vaccination inflammation

UR - http://www.scopus.com/inward/record.url?scp=85134543583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134543583&partnerID=8YFLogxK

U2 - 10.1016/j.ajoc.2022.101654

DO - 10.1016/j.ajoc.2022.101654

M3 - Article

C2 - 35818371

AN - SCOPUS:85134543583

SN - 2451-9936

VL - 27

JO - American Journal of Ophthalmology Case Reports

JF - American Journal of Ophthalmology Case Reports

M1 - 101654

ER -

Cataracts in setting of multisystem inflammation after COVID-19 vaccination

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this